References in periodicals archive ?
Objective: To find out effectiveness of revisional laparoscopic sleeve gastrectomy (RLSG) in the patients who had laparoscopic adjustable gastric banding (LAGB) and failed to reduce or regained the weight and effectiveness of sweet abstaining and exercise on postoperative weight loss.
2] who underwent laparoscopic adjustable gastric banding performed by a single surgeon and were followed for up to 11 years (mean of 10 years), 423 were aged 45 years or younger, and 405 were over age 45 years at the time of surgery.
Of 828 patients with body mass index of at least 35 kg/m2 who underwent laparoscopic adjustable gastric banding performed by a single surgeon and were followed for up to 11 years (mean of 10 years), 423 were aged 45 years or younger, and 405 were over age 45 years at the time of surgery.
The study reviewed the fertility outcomes after intragastric balloon placement, adjustable gastric banding, sleeve gastrectomy and gastric bypass in childbearing women with a diagnosis of infertility.
Weight loss and improvement in comorbidities are less than Roux-en-Y but definitely better then adjustable gastric banding.
Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review.
Contemporary bariatric surgeries include Roux-en-Y gastric bypass, laparoscopic adjustable gastric banding, biliopancreatic diversion with duodenal switch, sleeve gastrectomy, and mini--gastric bypass.
The most commonly used bariatric surgery techniques, according to the British Medical Journal, are Roux-en-Y gastric bypass, sleeve gastrectomy, and laparoscopic adjustable gastric banding.
Apollo Endosurgery Inc, a developer of medical devices for endoscopic surgical procedures, has acquired the obesity intervention division of Allergan Inc, which manufactures and sells weight loss solutions comprised of the LAP-BAND[R] adjustable gastric banding system and the ORBERA(TM) intra-gastric balloon system.
5 ( ANI ): Researchers have found that obese patients who underwent gastric bypass or laparoscopic adjustable gastric banding surgical procedures experienced substantial weight loss three years after surgery, with most of the change occurring in the first year itself.
In 2001 the LAP-BAND(r) adjustable gastric banding system (LAGB) was approved by the FDA as weight loss procedure for patients with a body mass index (BMI) of 40 kg/m2 or higher and for patients with a BMI of at least 35 with an obesity-related condition, such as diabetes or hypertension.
1,2,3,4,5,6) Fewer data exist on adverse neurologic effects following adjustable gastric banding and there are no well established therapeutic interventions for these complications when they occur.
Full browser ?